| http://www.w3.org/ns/prov#value | - During 2013, our assays and related products segment profitability was significantly affected by a number of items, including resolution of our molecular diagnostics distribution agreements, restructuring costs, and the write off of the Natural Molecular Testing Corporation receivable, said Harriss T. Currie, senior vice president and chief financial officer.
|
